Clinical trial Recruiting at 16 sites Observational Ages 18 and up

Assessing swallowing function in patients with neurodegenerative diseases

Official title: Prospective Observational Study for the Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases

Run by Kliniken Beelitz GmbH · NCT04706234 · Data updated 2026-11-12

This study looks at how well people with neurodegenerative diseases, like Parkinson's and Motor Neuron Disease, can swallow and how it affects their quality of life.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment350 (estimated)
SponsorKliniken Beelitz GmbH
Academic / other
Locations16 sites (Innsbruck, Tyrol and 15 other locations)
StatusRecruiting
StartedSeptember 1, 2017
Main results expectedDecember 31, 2027
Study endsJuly 31, 2028
Registry record updatedApril 9, 2025
Trial IDNCT04706234 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients diagnosed with Multiple System Atrophy, Progressive Supranuclear Palsy, Parkinson's Disease, Motor Neuron Disease, or other neurodegenerative diseases who have undergone laryngopharyngeal assessment.

Probably not a fit

Patients who do not consent to participate in the study will not benefit from its findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study systematically records the results of routine laryngeal examinations and specific characteristics of dysphagia in patients diagnosed with neurodegenerative disorders such as Multiple System Atrophy, Parkinson's Disease, and Motor Neuron Disease. It utilizes fiberoptic endoscopic evaluation of swallowing (FEES) and collects demographic and disease-specific data, along with administering two questionnaires related to swallowing disturbances and quality of life. The study aims to enhance understanding of laryngopharyngeal dysfunction and its implications for patient prognosis and treatment.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic tools and early interventions for dysphagia in patients with neurodegenerative diseases.

How similar studies have gone: While the systematic assessment of laryngopharyngeal function in neurodegenerative diseases is not extensively studied, the approach aligns with emerging diagnostic needs in the field, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* diagnosis of probable or possible multiple system atrophy according to current consensus criteria (Gilman et al. 2008) or
* diagnosis of probable or possible PSP according to the the Movement Disorders Society (MDS) diagnostic criteria (Höglinger et al. 2017) or
* diagnosis of Parkinson's disease according to the MDS diagnostic criteria (Postuma et al 2015)
* Hoehn and Yahr Stage within the range of I-V or
* diagnosis of motor neurone disease or
* diagnosis of a neurodegenerative disease other than specified above

AND underwent laryngopharyngeal assessment according to the systematic task protocol during FEES (Warnecke et al. 2019).

Exclusion Criteria:

\- Patients who do not sign the consent form

Where it's running

  • Department of Neurology and Department of ENT, Medical University Innsbruck
    Innsbruck, Tyrol, Austria
    Recruiting
  • Department of Neurology, Medical University of Ulm
    Ulm, Baden-Wurttemberg, Germany
    Recruiting
  • Movement Disorders Hospital - Kliniken Beelitz
    Beelitz-Heilstätten, Brandenburg, Germany
    Recruiting
  • Department of Neurology, Medical School Hannover
    Hanover, Lower Saxony, Germany
    Recruiting
  • Department of Neurology, University Hospital Münster
    Münster, North Rhine-Westphalia, Germany
    Recruiting
  • Department of Neurology, University Hospital Carl Gustav Carus
    Dresden, Saxony, Germany
    Recruiting
Show 10 more locations
  • Department of Neueology Asklepios Klinik Stadtroda
    Stadtroda, Thuringia, Germany
    Recruiting
  • Asklepios Fachklinikum Stadtroda
    Stadtroda, Thuringia, Germany
    Recruiting
  • Asklepios Klinik Barmbek
    Hamburg, Germany
    Recruiting
  • Department of Neurology Asklepios Klinik Barmbek
    Hamburg, Germany
    Recruiting
  • Department of Neurology, Movement Disorders Unit, Medical Center Tel Aviv
    Tel Aviv, Israel
    Recruiting
  • IRCCS Istituto delle Scienze Neurologiche, Azienda USL di Bologna
    Bologna, Italy
    Recruiting
  • Department of Neurology, Gifu University Graduate School of Medicine
    Gifu, Japan
    Recruiting
  • Department of Neurology, Medical University Warsaw
    Warsaw, Poland
    Recruiting
  • Department of Neurology SNUCM
    Seoul, South Korea
    Recruiting
  • Unidad de Parkinson y Trastornos del Movimiento Instituto Clínic de Neurociencias, Hospital Clinic de Barcelona
    Barcelona, Catalonia, Spain
    Recruiting

Study contacts

  • Principal investigator: Florin Gandor, MD — Movement Disorders Hospital Beelitz-Heilstätten, Germany
  • Study coordinator: Florin Gandor, MD
  • Email: gandor@kliniken-beelitz.de
  • Phone: +493320422781

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Neurodegenerative Diseases Registry

    This registry collects data from adults with neurodegenerative conditions to help doctors distinguish between Parkinsonian syndromes and related disorders and understand disease progression over time.

    Recruiting Chinese University of Hong Kong · Hong Kong · NCT04472130

  • Collecting data on neurodegenerative diseases progression markers

    This study is trying to find new signs that can help doctors understand how neurodegenerative diseases like Parkinson's progress, so they can improve early treatment options for patients.

    Recruiting IRCCS San Raffaele Roma · Cassino, Frosinone · NCT06596746

  • Biobank for studying ALS and Alzheimer's diseases

    This study is collecting blood, skin samples, and health information from people to see how genetics might help us understand and find treatments for ALS and Alzheimer's disease.

    Recruiting New York Stem Cell Foundation Research Institute · New York, New York · NCT06203106

  • Using neuroimaging to improve diagnosis and prognosis of Parkinson's disease and related conditions

    This study is trying to find brain imaging markers that can help doctors better diagnose and predict how Parkinson's disease and similar conditions will progress in patients.

    Recruiting University of Texas Southwestern Medical Center · Dallas, Texas · NCT03872102

  • A study on early diagnosis and biomarkers for dementia and related diseases

    This study is testing new ways to spot dementia and related diseases early by looking for specific markers in the brain and body, to help people at high risk and track how well new treatments are working.

    Recruiting at 2 sites Skane University Hospital · Ängelholm and 1 other locations · NCT03174938

  • Registering medical data and care outcomes for ALS, SMA, and other motor disorders

    This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.

    Recruiting Ambulanzpartner Soziotechnologie APST GmbH · Berlin, State of Berlin · NCT07900672

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.